A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
Status:
Completed
Trial end date:
2017-07-11
Target enrollment:
Participant gender:
Summary
A Phase 1, Randomized, Open-Label, 3-Way Crossover, Pilot, Pharmacokinetic Study to Evaluate
the Steady State Pharmacokinetics of a Once-Weekly Application of Corplex Donepezil
Transdermal Delivery System (TDS) Compared to Daily Oral Administration of Aricept in Healthy
Adult Subjects